Nanavaty Maulik
SEC insider (Form 3/4/5 filer). CIK 0001529708. Director at Rani Therapeutics Holdings, Inc. (RANI). 5 reported Form 4/5 transactions since Sep 2024; latest on May 28, 2025. Located in SAN JOSE, CA.
Companies Nanavaty Maulik has filed insider reports for
- Rani Therapeutics Holdings, Inc. (RANI): Director
Nanavaty Maulik
CIK: 0001529708
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rani Therapeutics Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 28, 2025RANI
Rani Therapeutics Holdings, Inc.
AwardDirectDirector Stock Option (Right to Buy)
50K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
DispositionDirectStock Option (Right to Buy)
101.3K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
AwardDirectStock Option (Right to Buy)
101.3K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
DispositionDirectStock Option (Right to Buy)
15.4K shares- - Dec 16, 2024RANI
Rani Therapeutics Holdings, Inc.
AwardDirectStock Option (Right to Buy)
15.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 28, 2025 | RANI Rani Therapeutics Holdings, Inc. | Award Director Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Disposition Stock Option (Right to Buy) | 101,276 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Award Stock Option (Right to Buy) | 101,276 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Disposition Stock Option (Right to Buy) | 15,423 | - | - | Direct |
| Dec 16, 2024 | RANI Rani Therapeutics Holdings, Inc. | Award Stock Option (Right to Buy) | 15,423 | - | - | Direct |
1-5 of 5 transactions